2014
DOI: 10.1016/j.gie.2014.02.615
|View full text |Cite
|
Sign up to set email alerts
|

Mo1438 Fluid Genetic Analyses Predict Biological Behavior of Pancreatic Cysts: 3-Year Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Nevertheless, this would probably not have affected the results because the patients included in our cohort were sent for EUS-FNA after inconclusive CT and MRI. (3) We did not include in our study new PCLs diagnostic tools for which the potential interests have been published during the conduct of the study, including DNA mutations [25,26], string sign tests [27], and EUS-guided microforceps biopsies [28]. (4) For the sake of simplification, therapeutic management was based on a consensus of a panel of five experts.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, this would probably not have affected the results because the patients included in our cohort were sent for EUS-FNA after inconclusive CT and MRI. (3) We did not include in our study new PCLs diagnostic tools for which the potential interests have been published during the conduct of the study, including DNA mutations [25,26], string sign tests [27], and EUS-guided microforceps biopsies [28]. (4) For the sake of simplification, therapeutic management was based on a consensus of a panel of five experts.…”
Section: Discussionmentioning
confidence: 99%
“…Molecular analysis of pancreatic cysts is an evolving tool for the evaluation of pancreatic cysts and has been shown to aid in the preoperative diagnosis. 23,[25][26][27][38][39][40][41][42] Our study investigated the impact of NGS on the presumptive clinical diagnosis of pancreatic cysts based on imaging features and clinical diagnosis based on CEA levels of the fluid. Our data show that NGS analysis of pancreatic cyst fluid changed the imaging diagnosis in 12% of patients, thus affecting patient management.…”
Section: Discussionmentioning
confidence: 99%
“…21,22 However, studies have shown that in the setting of a pancreatic cyst, a KRAS mutation is very specific for a mucinous etiology. [23][24][25][26] Similarly, GNAS mutations may be detected in PDAC, but in the setting of cyst fluid analysis, a GNAS mutation supports the imaging diagnosis of intraductal papillary mucinous neoplasm (IPMN), whereas the detection of the von Hippel-Lindau gene supports a serous cystadenoma. [27][28][29][30] The development of next-generation sequencing (NGS) enables rapid detection of mutations in a selected panel of cancer genes.…”
mentioning
confidence: 99%
“…Similarly, molecular mutation analyses in cystic neoplasia of the pancreas and of thyroid lesions of indeterminate cytology can be used to help differentiate benign from malignant lesions [16][17][18][19][20][21][22][23][24][25] . In suspected Stratification of cancer has now become a part of the primary diagnosis.…”
Section: Importance Of Molecular Diagnosis In Oncologymentioning
confidence: 99%